The Journal of the Korean Rheumatism Association 2008; 15(3): 222-229
Published online September 30, 2008
© Korean College of Rheumatology
남언정1ㆍ송은주1ㆍ김지민1ㆍ서재석1ㆍ사금희1ㆍ조현정1ㆍ박재용1,3ㆍ경희수2ㆍ김인산3,4ㆍ강영모1,3,4
경북대학교 의과대학 내과학교실1, 정형외과학교실2, 생화학교실3, 세포기질연구소4
Correspondence to : Young Mo Kang
Objective: Ղig-h3 is an extracellular matrix protein, which is overexpressed in synovial tissues of rheumatoid arthritis (RA) similar to adhesive glycoproteins. We sought to evaluate the compensatory role of Ղig-h3 with adhesive glycoproteins in mediating the adhesion of fibroblast- like synoviocytes (FLS) and to confirm the inhibitory effect of YH18 peptide of the 2nd fas-1 domain in Ղig-h3-mediated adhesion. Methods: The adhesion of FLS isolated from synovial tissues of RA, was evaluated in 96 well microtiter plate coated with matrix proteins. Inhibitory effect of YH18 peptides from the 2nd and 4th fas-1 domains was estimated in Ղig-h3-mediated adhesion of FLS. Results: The adhesion of FLS on Ղig-h3 was weaker than that of fibronectin and vitronectin. The Ղig-h3-mediated adhesion was enhanced by the stimulation with phorbol myristate acetate (PMA), but not by cytokines and growth factors. Combination of fibronectin with Ղig-h3 synergistically enhanced the adhesion of FLS, in contrast to the additive effect of vitronectin combined with Ղig-h3. YH18 peptide of the 2nd fas-1 domain did not block the Ղig-h3-mediated adhesion of FLS. Conclusion: Our results reveal that Ղig-h3 may regulate the adhesion of FLS through the interaction with adhesive glycoproteins and confirm that the essential motifs mediating adhesion on Ղig-h3 are different according to the type of cells.
Keywords Ղig-h3, Fas-1 domain, YH motif, Fibroblast-like synoviocyte, Rheumatoid arthritis
The Journal of the Korean Rheumatism Association 2008; 15(3): 222-229
Published online September 30, 2008
Copyright © Korean College of Rheumatology.
남언정1ㆍ송은주1ㆍ김지민1ㆍ서재석1ㆍ사금희1ㆍ조현정1ㆍ박재용1,3ㆍ경희수2ㆍ김인산3,4ㆍ강영모1,3,4
경북대학교 의과대학 내과학교실1, 정형외과학교실2, 생화학교실3, 세포기질연구소4
Eon Jeong Nam1, Eun Joo Song1, Ji Min Kim1, Jae Seok Seo1, Keum Hee Sa1, Hyung Jung Cho1, Jae Yong Park1,3, Hee-Soo Kyung2, In San Kim3,4, Young Mo Kang1,3,4
Departments of Internal Medicine1, Orthopedic Surgery2, Biochemistry and Cellular Biology3, Cell and Matrix Research Institute4, Kyungpook National University, School of Medicine, Daegu, Korea
Correspondence to:Young Mo Kang
Objective: Ղig-h3 is an extracellular matrix protein, which is overexpressed in synovial tissues of rheumatoid arthritis (RA) similar to adhesive glycoproteins. We sought to evaluate the compensatory role of Ղig-h3 with adhesive glycoproteins in mediating the adhesion of fibroblast- like synoviocytes (FLS) and to confirm the inhibitory effect of YH18 peptide of the 2nd fas-1 domain in Ղig-h3-mediated adhesion. Methods: The adhesion of FLS isolated from synovial tissues of RA, was evaluated in 96 well microtiter plate coated with matrix proteins. Inhibitory effect of YH18 peptides from the 2nd and 4th fas-1 domains was estimated in Ղig-h3-mediated adhesion of FLS. Results: The adhesion of FLS on Ղig-h3 was weaker than that of fibronectin and vitronectin. The Ղig-h3-mediated adhesion was enhanced by the stimulation with phorbol myristate acetate (PMA), but not by cytokines and growth factors. Combination of fibronectin with Ղig-h3 synergistically enhanced the adhesion of FLS, in contrast to the additive effect of vitronectin combined with Ղig-h3. YH18 peptide of the 2nd fas-1 domain did not block the Ղig-h3-mediated adhesion of FLS. Conclusion: Our results reveal that Ղig-h3 may regulate the adhesion of FLS through the interaction with adhesive glycoproteins and confirm that the essential motifs mediating adhesion on Ղig-h3 are different according to the type of cells.
Keywords: Ղ,ig-h3, Fas-1 domain, YH motif, Fibroblast-like synoviocyte, Rheumatoid arthritis
Young Mo Kang, M.D., Sung Il Kim, M.D.*, Jeong Seup Kim, M.S.*, Dong Wan You, Kheum Hee Sa, M.S., Eun Ju Park, B.S., Sung Uk Kim, M.D., Jae Seok Seo, M.D., Seung Woo Han, M.D., Eon Jeong Nam, M.D., Hee-Soo Kyung, M.D.**, Moon Gyu Kim, M.D.***, In San Kim, M.D., Jung Chol Kim, M.D.***
The Journal of the Korean Rheumatism Association 2005; 12(2): 73-82Soo Min Ahn, M.D., Ph.D., Seonok Kim, MSc., Ye-Jee Kim, Ph.D., Seokchan Hong, M.D., Ph.D., Chang-Keun Lee, M.D., Ph.D., Bin Yoo, M.D., Ph.D., Ji Seon Oh, M.D., Ph.D., Yong-Gil Kim, M.D., Ph.D.
J Rheum Dis -0001; ():Roshan Subedi, M.D., Afrah Misbah, M.D., Adnan Al Najada, M.D., Anthony James Ocon, M.D., Ph.D.
J Rheum Dis -0001; ():